Literature DB >> 22353035

Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis.

Jianzheng Zheng1, Anushka Dasgupta, Oscar A Bizzozero.   

Abstract

We recently reported that the proteasomal peptidase activities are altered in the cerebellum of mice with myelin oligodendrocyte glycoprotein (MOG) peptide-induced experimental autoimmune encephalomyelitis (EAE). To determine whether these fluctuations are caused by proteasome activation/inactivation and/or changes in the levels of individual β subunits, we characterized the proteasome subunit composition by western blotting. The results show that the rise in proteasomal peptidase activity in acute EAE correlates with an augmented expression of inducible β subunits whereas the decline in activity in chronic EAE correlates with a reduction in the amount of standard β subunits. Using pure standard (s) and immuno (i) 20S particles for calibration, we determined that the changes in the levels of catalytic subunits account for all of the fluctuations in peptidase activities in EAE. The i-20S and s-20S proteasome were found to degrade carbonylated β-actin with similar efficiency, suggesting that the amount of protein carbonyls in EAE may be controlled by the activity of both core particles. We also found an increase in proteasome activator 11S regulatory particle and a decrease in inhibitor proteasome inhibitor with molecular mass of 31 kDa levels in acute EAE, reflecting a response to inflammation. Elevated levels of 19S regulatory particle and 11S regulatory particle in chronic EAE, however, may occur in response to diminished proteasomal activity in this phase. These findings are central towards understanding the altered proteasomal physiology in inflammatory demyelinating disorders.
© 2012 The Authors. Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22353035      PMCID: PMC3323733          DOI: 10.1111/j.1471-4159.2012.07699.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  38 in total

1.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

2.  Immunoproteasome deficiency alters retinal proteasome's response to stress.

Authors:  Stacy A Hussong; Rebecca J Kapphahn; Stacia L Phillips; Marcela Maldonado; Deborah A Ferrington
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

3.  Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.

Authors:  Benoît Guillaume; Jacques Chapiro; Vincent Stroobant; Didier Colau; Benoît Van Holle; Grégory Parvizi; Marie-Pierre Bousquet-Dubouch; Ivan Théate; Nicolas Parmentier; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

4.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

5.  The immunoproteasome, the 20S proteasome and the PA28αβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes.

Authors:  Andrew M Pickering; Alison L Koop; Cheryl Y Teoh; Gennady Ermak; Tilman Grune; Kelvin J A Davies
Journal:  Biochem J       Date:  2010-12-15       Impact factor: 3.857

6.  Decreased activity of the 20S proteasome in the brain white matter and gray matter of patients with multiple sclerosis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2011-02-09       Impact factor: 5.372

7.  Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice.

Authors:  Marcel Kremer; Anja Henn; Cornelia Kolb; Michael Basler; Jacqueline Moebius; Benoît Guillaume; Marcel Leist; Benoît J Van den Eynde; Marcus Groettrup
Journal:  J Immunol       Date:  2010-09-29       Impact factor: 5.422

8.  Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

9.  Reduced proteasomal activity contributes to the accumulation of carbonylated proteins in chronic experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2010-11-19       Impact factor: 5.372

Review 10.  Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy.

Authors:  Honglin Luo; Jerry Wong; Brian Wong
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

View more
  14 in total

1.  Decreased levels of constitutive proteasomes in experimental autoimmune encephalomyelitis may be caused by a combination of subunit displacement and reduced Nfe2l1 expression.

Authors:  Kara L Shanley; Che-Lin Hu; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2019-12-02       Impact factor: 5.372

2.  Proteasome Composition in Cytokine-Treated Neurons and Astrocytes is Determined Mainly by Subunit Displacement.

Authors:  Kara L Shanley; Che-Lin Hu; Oscar A Bizzozero
Journal:  Neurochem Res       Date:  2020-01-14       Impact factor: 3.996

3.  Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.

Authors:  Kimberly Cornish Carmony; Lalit Kumar Sharma; Do-Min Lee; Ji Eun Park; Wooin Lee; Kyung-Bo Kim
Journal:  Chembiochem       Date:  2014-12-04       Impact factor: 3.164

4.  A FRET-based approach for identification of proteasome catalytic subunit composition.

Authors:  Ji Eun Park; Ying Wu; Kimberly Cornish Carmony; Zachary Miller; Lalit Kumar Sharma; Do-Min Lee; Doo-Young Kim; Wooin Lee; Kyung-Bo Kim
Journal:  Mol Biosyst       Date:  2014-02

Review 5.  Inhibitors of the immunoproteasome: current status and future directions.

Authors:  Zachary Miller; Lin Ao; Kyung Bo Kim; Wooin Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.

Authors:  Alexey Belogurov; Ekaterina Kuzina; Anna Kudriaeva; Alexey Kononikhin; Sergey Kovalchuk; Yelena Surina; Ivan Smirnov; Yakov Lomakin; Anna Bacheva; Alexey Stepanov; Yaroslava Karpova; Yulia Lyupina; Oleg Kharybin; Dobroslav Melamed; Natalia Ponomarenko; Natalia Sharova; Eugene Nikolaev; Alexander Gabibov
Journal:  FASEB J       Date:  2015-01-29       Impact factor: 5.191

Review 7.  The ubiquitin proteasome system in glia and its role in neurodegenerative diseases.

Authors:  Anne H P Jansen; Eric A J Reits; Elly M Hol
Journal:  Front Mol Neurosci       Date:  2014-08-08       Impact factor: 5.639

8.  Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?

Authors:  Kyung Bo Kim
Journal:  Cancer Drug Resist       Date:  2021-05-30

9.  Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.

Authors:  Anushka Dasgupta; Jianzheng Zheng; Nora I Perrone-Bizzozero; Oscar A Bizzozero
Journal:  ASN Neuro       Date:  2013       Impact factor: 4.146

Review 10.  Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.

Authors:  Elena Bellavista; Aurelia Santoro; Daniela Galimberti; Cristoforo Comi; Fabio Luciani; Michele Mishto
Journal:  Autoimmune Dis       Date:  2014-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.